FEASIBILITY & ENVIRONMENTAL ASESSMENT
The first step for connecting rare disease patients to orphan drugs therapies is to understand its value-chain and the involved stakeholders. OrphanDC offers a tailor-made Feasibility & Environmental Assessment service, focused on providing an integrated process for trial acceleration with the best environment for our clients’ performance.
Hematology
Nephrology
Oncology
Ophthalmology
Pneumonology
Neurology
COVID-19